Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer’s disease-like pathologies in APP/PS1 mouse model

OBJECTIVE: Alzheimer's disease (AD) is along with cognitive decline due to amyloid-β (Aβ) plaques, tau hyperphosphorylation, and neuron loss. Shenqi Xingnao Granules (SQXN), a traditional Chinese medicine, significantly ameliorated the cognitive function and daily living abilities of patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Cui-cui, Jia, Xiao-yu, Zhang, Li, Li, Ya-li, Zhang, Zhan-jun, Li, Lin, Zhang, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476633/
https://www.ncbi.nlm.nih.gov/pubmed/36120170
http://dx.doi.org/10.1016/j.chmed.2020.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476633/
https://www.ncbi.nlm.nih.gov/pubmed/36120170
http://dx.doi.org/10.1016/j.chmed.2020.04.005

Ejemplares similares